SVB Financial Group’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

SVB Financial Group’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,950	Closed	-$5.08K	–	24
2023 Q2	$5.08K	Hold	16,950	–	–	0.01%	24
2023 Q1	$7.33K	Hold	16,950	–	–	0.01%	28
2022 Q4	$20K	Buy	+16,950	New	+$27.6K	0.05%	28

SVB Financial Group's GRNA Position: Q3 2023 in Review

SVB Financial Group sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 16,950 shares — an estimated $5.08K sold.

SVB Financial Group first reported a position in GRNA in Q4 2022 and held it in 3 quarters. The position peaked at $20K in Q4 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

SVB Financial Group reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
SVB Financial Group sold 16,950 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $5.08K.
SVB Financial Group first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q4 2022 and held it in 3 quarters.
SVB Financial Group's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $20K in Q4 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on SVB Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.